alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS
ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, J. Scott Kamsler, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report of Exar Corporation on Form
10-Q for the period ended December 30, 2007 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all
material respects, the financial condition and results of operations of Exar Corporation.

Date: February 8, 2008



|                                                 
|-------------------------------------------------
|/s/ J. SCOTT KAMSLER                             
|J. Scott Kamsler                                 
|Senior Vice President and Chief Financial Officer
|(Principal Financial and Accounting Officer)
II 

Calendar No. 464 

112TH CONGRESS 

2D SESSION S. 285 

For the relief of Sopuruchi Chukwueke. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 3, 2011 

Mr. LEVIN introduced the following bill; which was read twice and referred 

to the Committee on the Judiciary 

JULY 19, 2012 

Reported by Mr. LEAHY, with an amendment 

[Insert the part printed in italic] 

A BILL 

For the relief of Sopuruchi Chukwueke. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ADJUSTMENT OF STATUS. 

4 (a) IN GENERAL.—Notwithstanding any other provi5 sion of law, for the purposes of the Immigration and Na6 tionality Act (8 U.S.C. 1101 et seq.), Sopuruchi 

7 Chukwueke shall be deemed to have been lawfully admit8 ted to, and remained in, the United States, and shall be 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•S 285 RS

1 eligible for adjustment of status to that of an alien law2 fully admitted for permanent residence under section 245 

3 of the Immigration and Nationality Act (8 U.S.C. 1255) 

4 upon filing an application for such adjustment of status. 

5 (b) APPLICATION AND PAYMENT OF FEES.—Sub6 section (a) shall apply only if the application for adjust7 ment of status is filed with appropriate fees not later than 

8 2 years after the date of the enactment of this Act. 

9 (c) REDUCTION OF IMMIGRANT VISA NUMBERS.— 

10 Upon the granting of permanent resident status to 

11 Sopuruchi Chukwueke, the Secretary of State shall in12 struct the proper officer to reduce by 1, during the current 

13 or next following fiscal year, the total number of immi14 grant visas that are made available to natives of the coun15 try of the birth of Sopuruchi Chukwueke under section 

16 202(a)(2) of the Immigration and Nationality Act (8 

17 U.S.C. 1152(a)(2)). 

18 (d) DENIAL OF PREFERENTIAL IMMIGRATION TREAT19 MENT FOR CERTAIN RELATIVES.—The natural parents, 

20 brothers, and sisters of Sopuruchi Victor Chukwueke shall 

21 not, by virtue of such relationship, be accorded any right, 

22 privilege, or status under the Immigration and Nationality 

23 Act (8 U.S.C. 1101 et seq.). 

mstockstill on DSK4VPTVN1PROD with BILLS

mstockstill on DSK4VPTVN1PROD with BILLS

Calendar No. 464 

112TH CONGRESS 

2D SESSION S. 285 

A BILL 

For the relief of Sopuruchi Chukwueke. 

JULY 19, 2012 

Reported with an amendment 

mstockstill on DSK4VPTVN1PROD with BILLS
II 

112TH CONGRESS 

2D SESSION S. 2837 

To suspend temporarily the duty on propylene glycol alginates. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Ms. COLLINS introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on propylene glycol 

alginates. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PROPYLENE GLYCOL ALGINATES. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.--.-- Propylene glycol alginates 

(CAS No. 9005–37–2) (provided for in subheading 

3913.10.00) ........................... Free No change No change On or before 

12/31/2015 ’’. 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2837 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
Meeting Summary: Food Marketing Institute (FMI) on Leak Repair Amendments / GreenChill

Wed 03/02/2011 10:00 am – 11:00 am

Room 152, 1310 L Street, NW, Washington DC 

On March 3, 2011, EPA/OAR staff met with representatives from the Food Marketing Institute 

(FMI) and five of its grocery store chain members. The meeting afforded members of the 

industry a chance to further comment and request clarification on elements of the leak repair 

proposed amendments. In particular, representatives from FMI, Safeway and Target reiterated a 

number of the concerns expressed in the docket about the potential cost of failing a third test, of 

requiring a follow-up test 24 hours after a successful test and of the impact the proposal might 

have on small businesses. Several industry representatives also requested clarification about the 

definition of “appliance” versus “component” and what type of on-site record keeping will be 

needed to meet the new requirements. The attendees were encouraged to use the extended 

comment period ending on March 25 to detail and expand on these and any other concerns or 

suggestions.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2775 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2775

    To suspend temporarily the duty on N,N',N"-[(2,4,6-trioxo-1,3,5-
   triazine-1,3,5(2H,4H,6H)-triyl)tris[methylene(3,5,5-trimethyl-3,1-
   cyclohexanediyl)]]tris[hexahydro-2-oxo-1H-azepine-1-carboxamide].

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the duty on N,N',N"-[(2,4,6-trioxo-1,3,5-
   triazine-1,3,5(2H,4H,6H)-triyl)tris[methylene(3,5,5-trimethyl-3,1-
   cyclohexanediyl)]]tris[hexahydro-2-oxo-1H-azepine-1-carboxamide].

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. N,N',N"-[(2,4,6-TRIOXO-1,3,5-TRIAZINE-1,3,5(2H,4H,6H)-
              TRIYL)TRIS[METHYLENE(3,5,5-TRIMETHYL-3,1-
              CYCLOHEXANEDIYL)]] TRIS[HEXAHYDRO-2-OXO-1H-AZEPINE-1-
              CARBOXAMIDE].

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      N,N',N"-[(2,4,6-    Free         No change        No change        On or before 12/  ''.
                        Trioxo-1,3,5-                                                      31/2015.......
                        triazine-
                        1,3,5(2H,4H,6H)-
                        triyl)tris[methyl
                        ene(3,5,5-
                        trimethyl-3,1-
                        cyclohexanediyl)]
                        ]tris[hexahydro-2-
                        oxo-1H-azepine-1-
                        carboxamide] (CAS
                        No. 68975-83-7)
                        in organic
                        solvent (provided
                        for in subheading
                        3911.90.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

      ( print page 17863)    
The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).

The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than May 1, 2009.

**A. Federal Reserve Bank of St. Louis**                     (Glenda Wilson, Community Affairs Officer) P.O. Box 442, St. Louis, Missouri 63166-2034:                

*1. Monte M. Doing*, Springfield, Missouri, individually, and in concert with Glen Garrett, Purdy, Missouri; Ozark Heritage Financial Group, Inc., Springfield, Missouri; Rocky R. Levell, Naples, Florida; John E. Sherwood, Miromar Lakes, Florida; Jerry Scott Whisman, Monett, Missouri; Dennis K. Marlin, and Kenneth A. Schwab, both of Springfield, Missouri, to acquire voting shares of OakStar Bancshares, Inc., and thereby indirectly acquire voting shares of OakStar Bank, N.A., both of Springfield, Missouri.                

**B. Federal Reserve Bank of Dallas**                     (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201-2272:                

*1. Patrick W. Hopper (as trustee of the PWH Trust UTD 3/2/94)*, Henderson, Nevada; to acquire additional voting shares of Professional Capital, Inc., and thereby indirectly acquire additional voting shares of Professional Bank, National Association, both of Dallas, Texas.                

Board of Governors of the Federal Reserve System, April 13, 2009.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. E9-8768 Filed 4-16-09; 8:45 am]

BILLING CODE 6210-01-S
Revised Summary of Compensation Arrangement Applicable to the Registrant's



 Exhibit 10.39 
 REVISED SUMMARY OF COMPENSATION ARRANGEMENT 
 APPLICABLE TO THE COMPANY’S NAMED EXECUTIVE
OFFICERS 
 As of March 12, 2008, the following represents the compensation of the executive officers of NMT Medical, Inc. (the
“Company”): 
  

									
	 	  	2008 Compensation
	 Executive Officer
	  	Annual
Salary	  	Bonus for Work
Performed in 2007	  	Shares Underlying
Stock Options
Granted in 2007
	 John E. Ahern
President and Chief Executive Officer
	  	$	460,000	  	$	55,000	  	45,750
	 Richard E. Davis
Executive Vice President and Chief Financial Officer
	  	$	345,000	  	$	43,000	  	31,750
II 

112TH CONGRESS 

2D SESSION S. 2909 

To require closing costs to be paid by the enterprises with respect to certain 

refinanced mortgage loans, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. MERKLEY introduced the following bill; which was read twice and referred 

to the Committee on Banking, Housing, and Urban Affairs 

A BILL 

To require closing costs to be paid by the enterprises with 

respect to certain refinanced mortgage loans, and for 

other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Rebuilding Equity Act 

5 of 2012’’. 

6 SEC. 2. REBUILDING EQUITY PROGRAM. 

7 (a) IN GENERAL.—The Federal National Mortgage 

8 Association and the Federal Home Loan Mortgage Cor9 poration (in this Act referred to as the ‘‘enterprises’’) shall 

10 each establish a voluntary program for borrowers who 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 2909 IS

1 qualify for the Home Affordable Refinance Program car2 ried out by the enterprises, in which the enterprises shall 

3 pay for the closing costs associated with applying for and 

4 receiving the refinancing when the borrower agrees to refi5 nance into a fully amortizing loan with a term of not 

6 longer than 20 years. 

7 (b) INCLUSIONS.—Closing costs covered by this sec8 tion shall include— 

9 (1) application fees; 

10 (2) credit check costs; 

11 (3) title search costs; and 

12 (4) attorneys’ fees associated with closing the 

13 transaction, other than attorneys’ fees associated 

14 with disputes arising out of the transaction or other15 wise ancillary to closing the transaction. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS
EX-10.25 DESCRIPTION/ARRANGEMENT FOR DIRECTOR FEES



 





Exhibit 10.25




DESCRIPTION OF ARRANGEMENT FOR DIRECTORS FEES



The following sets forth the amount of fees payable to outside directors of S1 Corporation as of
December 31, 2007 for their services as Directors:




	 	 	 	 	 
	EVENT	 	FEE	 
	 
	 
	 	 	 	 
	Annual Retainer (Board Chairman)
	 	$	150,000	 
	Annual Retainer (excluding Board Chairman)
	 	$	20,000	 
	Board Meeting Attended (In Person)
	 	$	2,000	 
	Board Meeting Attended (By Phone)
	 	$	1,000	 
	Annual Committee Chair Retainer (Audit)
	 	$	20,000	 
	Annual Committee Chair Retainer (Strategic Planning)
	 	$	20,000	 
	Annual Committee Chair Retainer (Governance)
	 	$	10,000	 
	Annual Committee Chair Retainer (Compensation)
	 	$	10,000	 
	Annual Committee Chair Retainer (Finance)
	 	$	10,000	 
	Committee Meeting Attended (In Person)
	 	$	1,500	 
	Committee Meeting Attended (By Phone)
	 	$	1,000	 






	 	 	 	 	 
	 	 	# of Shares	 
	Annual Stock Option Grant
	 	 	15,000	 
	Annual Restricted Stock Grant
	 	 	3,000
Amendment to Restricted Stock Agreement



 Exhibit 10.320 
 AMENDMENT TO RESTRICTED STOCK AGREEMENT 
 THIS AMENDMENT TO RESTRICTED STOCK AGREEMENT (this
“Amendment”) is made as of January 31, 2008, by and between LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (the
“Company”), and John L. Higgins (“Participant”). 
 WHEREAS, the Company and Participant are
parties to that certain Restricted Stock Award Grant Notice and Restricted Stock Award Agreement dated as of February 1, 2007 (the “Original Agreement”); and 
 WHEREAS, the Company and Participant desire to amend the Original Agreement as set forth herein; and 
 WHEREAS, the Board of Directors of the Company has approved the adoption of this Amendment. 
 NOW, THEREFORE, BE IT RESOLVED, that the Original Agreement is hereby amended as follows: 
 1. The Vesting Schedule set forth in the Restricted Stock Award Grant Notice set forth in the Original Agreement is hereby amended to read as follows:

  

	 	Vesting Schedule:	Fifty percent (50%) of the Shares shall vest on the date that is three days following the Company’s public release of its audited financial statements for the
fiscal year ending December 31, 2007, and fifty percent (50%) of the Shares shall vest on February 15, 2009, subject to Participant’s continuous service with the Company through each such date. 

 2. Except as expressly provided for in this Amendment, no other term or provision of the Original Agreement is amended or modified in any respect.

 IN WITNESS WHEREOF, the parties have duly executed this Amendment as of the date first set forth above. 
  

									
	COMPANY:	 		 	PARTICIPANT:
			
	LIGAND PHARMACEUTICALS INCORPORATED a Delaware corporation	 		 	
					
	By:	 	/s/    CHARLES BERKMAN        	 		 		 	/s/    JOHN L. HIGGINS        
	Name:	 	Charles Berkman	 		 		 	John L. Higgins
	Title:	 	Vice, President, General Counsel and Secretary
Order entered February 2, 2017

In The 

## Court of Appeals **Fifth District of Texas at Dallas**

No. 05-17-00046-CV

IN RE MICHAEL C. WADE, Relator

Original Proceeding from the 397th Judicial District Court Grayson County, Texas Trial Court Cause No. 051329



### ORDER Before Justices Bridges, Fillmore, and Schenck

Based on the Court’s opin ion of this date, we DENY relator’s January 12, 2017 petition

for writ of mandamus.

/s/ DAVID L. BRIDGES
JUSTICE
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2894 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2894

          To suspend temporarily the duty on butane, 1-chloro.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Mr. Menendez introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
          To suspend temporarily the duty on butane, 1-chloro.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BUTANE, 1-CHLORO.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Butane, 1-chloro    Free         No change        No change        On or before 12/  ''.
                        (CAS No. 109-69-                                                   31/2015.......
                        3) (provided for
                        in subheading
                        2903.19.60)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
damhexh10_3.htm








Exhibit 10.3


 


 


SCHEDULE A







ASSUMPTION AND INDEMNIFICATION AGREEMENT


 


This Agreement (this “Agreement”) is made and entered into as of October 27, 2011 by and among DAM Holding, Inc. (“DAMH”) and Delaware American Motors, Inc. (“DAMINC”) together with its wholly-owned subsidiary, Delaware American Motors, LLC (“DAMLLC”) (DAMINC and DAMLLC collectively referred to as the “Subsidiary”).







WHEREAS, on or about October 27, 2011, Subsidiary was purchased from DAMH by the former sole officer of DAMH (the “Subsidiary Sale”);







WHEREAS, as a condition to the Subsidiary Sale, the Subsidiary is required to assume any debt or obligation of DAMH related to the Subsidiary and to indemnify DAMH from any debt or obligation of the Subsidiary.







NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, the parties hereto mutually agree as follows:







1. Assumption. Subsidiary hereby assumes, undertakes, accepts and agrees to promptly pay, perform and discharge any debt or obligation of Subsidiary and any debt or obligation of DAMH which pertains to or is related to the business of Subsidiary as specifically set forth on Exhibit A hereto  (the “Assumed Obligations”).







2.  Indemnification. Subsidiary hereby indemnifies and agrees to hold harmless DAMH, against and in respect of the Assumed Obligations and other liability, damage or deficiency, all actions, suits, proceedings, demands, assessments, judgments, costs and expenses, including attorney's fees, incident to the prior or future operation of Subsidiary.







3.  Counterparts.  This Agreement may be executed by the parties in separate counterparts, each of which when so executed and delivered will be deemed an original, but all of which together will constitute one and the same agreement.  In pleading or proving this Agreement, it will not be necessary to produce or account for more than one such counterpart.







4.  Binding Effect and Benefits.  This Agreement will bind and inure to the benefit of the parties hereto and their respective successors and permitted assigns. Nothing in this Agreement is intended to or will confer any rights or remedies on any person other than the parties hereto, their respective successors and permitted assigns.







5.  Captions.  The captions of sections or subsections of this Agreement are for reference only and will not affect the interpretation or construction of this Agreement.
















  





  











  






 


 


IN WITNESS WHEREOF, the parties hereto have entered into and signed this Agreement as of the date and year first above written.


 




	 	DAM HOLDING, INC.	 
	 	 	 	 
	 	 	 	 
	
 

	
By: 

	/s/ Fouad Kallamni	 
	 	Title:	President	 
	 	 	 	 
	 	 	 	 
	 	DELAWARE AMERICAN MOTORS, INC.	 
	 	 	 	 
	 	By:	/s/ Mark S. Klein	 
	 	 	 	 
	 	 	 	 
	 	DELAWARE AMERICAN MOTORS, LLC	 
	 	 	 	 
	 	By:	/s/ Mark S. Klein	 







 


 


 


 


 


 


 


 


 


 


 


 




  





  











  








 


SCHEDULE 1


ASSUMED DEBTS AND OBLIGATIONS







“NONE”
Exhibit 99.1
                                 ------------

                      COUNTRYWIDE HOME LOANS SERVICING LP


                             OFFICERS' CERTIFICATE
                    ANNUAL STATEMENT OF THE MASTER SERVICER


                                  CWALT, INC.
                       ALTERNATIVE LOAN TRUST 2004-24CB
             MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2004-24CB


     The undersigned do hereby certify that they are each an officer of
Countrywide GP, Inc., general partner of Countrywide Home Loans Servicing LP
(a "Master Servicer"), and do hereby further certify pursuant to Section 3.16
of the Pooling and Servicing Agreement for the above-captioned Series (the
"Agreement") that:

     (i) A review of the activities of the Master Servicer during the
preceding calendar year and of the performance of the Master Servicer under
the Agreement has been made under our supervision; and

     (ii) To the best of our knowledge, based on such review, the Master
Servicer has fulfilled all its obligations under the Agreement throughout such
year.




/s/ Joseph M. Candelario                                Dated: March 29, 2005
------------------------

JOSEPH M. CANDELARIO
FIRST VICE PRESIDENT



/s/ Mark Wong                                           Dated: March 29, 2005
------------
MARK WONG
SENIOR VICE PRESIDENT